Among patients with heart failure and reduced ejection fraction (HFrEF), those taking a "polypill" combination of three ...
Adults with heart failure with reduced ejection fraction (HFrEF) who took a "polypill" combining medications prescribed for ...
BOSTON, Stealth BioTherapeutics (Stealth), a clinical-stage biopharmaceutical company developing investigational drugs to treat mitochondrial dysfunction, today announced the initiation of two Phase 2 ...
Medera Inc. ("Medera"), a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by developing next-generation therapeutics, today announced that the first patient has ...
News Medical on MSN
Single daily polypill improves heart function and quality of life in heart failure patients
Adults with heart failure with reduced ejection fraction (HFrEF) who took a "polypill" combining medications prescribed for the treatment of heart failure, had improved heart function and symptoms, ...
Objective The left atrial stiffness index (LASI) has been proven to be a promising marker for assessing left atrial (LA) and ...
BOSTON, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Medera Inc. ("Medera"), a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by developing next-generation therapeutics, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback